Log In
Friday 22nd June 2018

BMS explores options

31st January 2007

US drugmaker Bristol-Myers Squibb has appointed top Wall Street bank Lehman Brothers to work alongside Citigroup and Morgan Stanley ahead of an expected takeover attempt from France's Sanofi.

The move paves the way for a bidding war for the US$51bn (€39bn) US company by attracting rival pharmaceuticals groups such as Pfizer, Schering-Plough and Merck.

Sanofi hasn't yet hired any bank to advise it, and may have been caught by surprise when its designs on Bristol-Myers Squibb were leaked to the media.

Sanofi's blood-thinning drug Plavix is marketed in the United States by Bristol-Myers Squibb.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2018